Apex Capital’s Array Biopharma ARRY Stock Holding History
Bought
Maintained
Sold
Other funds holding ARRY
BBA
Apex Capital's ARRY Position: Q2 2015 in Review
Apex Capital sold out of Array Biopharma (ARRY) in Q2 2015, closing a stake of 1,550,000 shares — an estimated $11.4M sold.
Apex Capital first reported a position in ARRY in Q2 2013 and held it in 8 quarters. The position peaked at $16.4M in Q2 2014. 148 funds tracked by Wall St. Rank hold ARRY as of Q2 2015.
- Apex Capital reported no remaining Array Biopharma position as of Q2 2015 after selling out during the quarter.
- Apex Capital sold 1,550,000 Array Biopharma shares in Q2 2015, an estimated $11.4M.
- Apex Capital first reported a position in Array Biopharma in Q2 2013 and held it in 8 quarters.
- Apex Capital's Array Biopharma position peaked at $16.4M in Q2 2014.
- 148 funds tracked by Wall St. Rank held Array Biopharma as of Q2 2015.
Based on Apex Capital's 13F filing for Q2 2015, filed 28 Jul 2015.